Biosenta IncCanadian Securities Exchange:ZRO
- LAST PRICE0.3350
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.3300/ 5
- Ask / Lots0.4950/ 2
- Open / Previous Close0.0000 / 0.3350
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | ZRO |
|---|
Yesterday
Biosenta Closes Private Placement Financing, from 5 hours ago by Dow Jones
5 hours ago by Dow Jones
Apr 19, 2024
Biosenta Announces Private Placement Financing, from 6:00PM ET on Friday Apr 19, 2024 by Dow Jones
6:00PM ET on Friday Apr 19, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biosenta Inc | 10.1M | -1.3x | --- |
Company Information
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It also develops chemical compounds designed to eliminate harmful microorganisms, such as bacteria, fungi, and viruses for household and industrial uses, while ensuring safety for both humans and the environment. It offers true Disinfectant and Tri-Filler. The true disinfectant is recognized by Health Canada for use in the fight against COVID-19. Its true technology leads the charge against the threat of superbug pathogens. The Tri-Filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-Filler are embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain to protect the drywall of buildings, objects, such as resin furniture, resin, textiles and others.
Contact Information
- Headquarters
- 18 Wynford Drive, Suite 704TORONTO, ON, Canada M3C 3S2
- Phone
- 416-410-2019
- Fax
- 416-410-6703
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $10.1M |
|---|---|
Revenue (TTM) | $930.00 |
Shares Outstanding | 30.2M |
Biosenta Inc does not pay a dividend. | |
Beta | 0.31 |
EPS | $-0.25 |
Book Value | $-0.30 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 10,892.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -677,397.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
